Keyphrases
Accurate Diagnosis
50%
Age Impact
50%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
50%
Antiplatelet
50%
Apnea Testing
50%
Atelectasis
50%
B Vitamins
75%
Bedside Monitoring
50%
Bedside Techniques
50%
Brain Oxygenation
50%
Cerebral Blood Flow
50%
Cerebral Vasculature
50%
Cerebral Vasospasm
50%
Clinical Experience
50%
Delayed Cerebral Ischemia
50%
Differential Effects
50%
Donation after Brain Death
50%
Effective Treatment
50%
Hemodynamic Alteration
50%
High Dose
33%
Homocysteine
53%
Homocysteine-lowering Therapy
50%
Imaging Assessment
50%
Intracerebral Hemorrhage
50%
Intraventricular Hemorrhage
50%
Jugular Venous Oximetry
50%
Metabolic Alterations
50%
Microdialysis
50%
Myocardial Infarction
64%
Near-infrared Spectroscopy
50%
Neurocritical Care
50%
Neurology
50%
Numbness
50%
Organ Donor
50%
Outcome Prediction
50%
Oxygenation
50%
Prevention Trials
57%
Randomized Controlled Trial
33%
Recruitment Maneuver
50%
Recurrent Stroke
64%
Recurrent Vascular Events
50%
Serum Homocysteine
50%
Stroke Prevention
57%
Stroke Survivors
40%
Subarachnoid Hemorrhage
50%
Thermal Diffusion
50%
Treatment Options
50%
Vasospasm
50%
Vitamin Therapy
87%
Vitamins
64%
Medicine and Dentistry
Antiplatelet
50%
Apnea
50%
Apoplexy
100%
Atelectasis
50%
Brain Blood Flow
25%
Brain Death
50%
Brain Injury
6%
Brain Ischemia
25%
Brain Tissue
25%
Brain Vasospasm
25%
Cardiovascular Risk
6%
Cardiovascular System
7%
Cerebral Hemorrhage
50%
Cervical Spine
25%
Clinical Trial
6%
Computer Assisted Tomography
6%
Continuous Positive Airway Pressure
6%
Donor Management
6%
Drug Megadose
18%
Finger
25%
Fraction of Inspired Oxygen
6%
Hazard Ratio
9%
Hemodynamic
25%
Homocysteine
93%
Hypotension
6%
Hypoxemia
31%
Image Analysis
6%
Kidney Function
6%
Limb
25%
Low Drug Dose
9%
Lung
31%
Magnetic Resonance Imaging
25%
Modified Rankin Scale
5%
Myocardial Infarction
59%
near Infrared Spectroscopy
25%
Neurology
50%
Organ Donor
50%
Oximetry
25%
Paresthesia
50%
Post-Hoc Analysis
19%
Proprioception
25%
Randomized Controlled Trial
19%
Subarachnoid Hemorrhage
50%
Subgroup Analysis
6%
Toe
25%
Vascularity
25%
Vasospasm
25%
Vitamin B12
28%
Weakness
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiplatelet
50%
Brain Hemorrhage
50%
Brain Ischemia
25%
Brain Vasospasm
25%
Cardiovascular Risk
6%
Cerebrovascular Accident
100%
Clinical Trial
6%
Heart Infarction
59%
Homocysteine
93%
Infrared Spectroscopy
25%
Microdialysis
25%
Paresthesia
50%
Randomized Controlled Trial
19%
Rankin Scale
5%
Subarachnoid Hemorrhage
50%
Vasospasm
25%
Vitamin B12
31%
Weakness
25%
